|
"tsou hh"的相關文件
顯示項目 71-80 / 116 (共12頁)
<< < 3 4 5 6 7 8 9 10 11 12 > >>
每頁顯示[10|25|50]項目
| 國家衛生研究院 |
2013-09 |
Functional genetic polymorphisms in CYP2C19 Gene in relation to cardiac side effects and treatment dose in a methadone maintenance cohort
|
Wang, SC;Ho, IK;Tsou, HH;Liu, SW;Hsiao, CF;Chen, CH;Tan, HK;Lin, L;Wu, CS;Su, LW;Huang, CL;Yang, YH;Liu, ML;Lin, KM;Liu, SC;Wu, HY;Kuo, HW;Chen, AC;Chang, YS;Liu, YL |
| 國家衛生研究院 |
2013-08-19 |
A consistency approach for evaluation of biosimilar products
|
Tsou, HH;Chang, WJ;Hwang, WS;Lai, YH |
| 國家衛生研究院 |
2013-07-23 |
Hepatitis C Virus infection influences the S-methadone metabolite plasma concentration
|
Wu, SL;Wang, SC;Tsou, HH;Kuo, HW;Ho, IK;Liu, SW;Hsu, YT;Chang, YS;Liu, YL |
| 國家衛生研究院 |
2013-07 |
CYP1A2 genetic polymorphisms are associated with early antidepressant escitalopram metabolism and adverse reactions
|
Kuo, HW;Liu, SC;Tsou, HH;Liu, SW;Lin, KM;Lu, SC;Hsiao, MC;Hsiao, CF;Liu, CY;Chen, CH;Lu, ML;Shen, WW;Tang, HS;Liu, SI;Chang, LH;Wu, HY;Chang, YS;Yeh, TK;Chen, AC;Liu, YL |
| 國家衛生研究院 |
2013-06-27 |
Dissecting the EGFR-PI3K-AKT pathway in oral cancer highlights the role of the EGFR variant III and its clinical relevance
|
Chang, KY;Tsai, SY;Chen, SH;Tsou, HH;Yen, CJ;Liu, KJ;Fang, HL;Wu, HC;Chuang, BF;Chou, SW;Tang, CK;Liu, SY;Lu, PJ;Yen, CY;Chang, JY |
| 國家衛生研究院 |
2013-05 |
KRAS mutation status-stratified randomized phase II trial of GEMOX with and without cetuximab in advanced biliary tract cancer (ABTC): The TCOG T1210 trial
|
Chen, LT;Chen, JS;Chao, Y;Tsai, CS;Shan, YS;Hsu, C;Huang, SF;Tsou, HH;Lee, KD;Chiu, CF;Rau, KM;Ho, CL;Yu, MS;Taiwan Cooperative Oncology Group |
| 國家衛生研究院 |
2013-04 |
Comparing multiple testing correction methods between two softwares for single nucleotide polymorphisms association analyses: Using OPRD1 and diastolic blood pressure in methadone maintenance patients as an example
|
Chang, YS;Tsou, HH;Wang, SC;Fang, CP;Liu, YL;Ho, IK |
| 國家衛生研究院 |
2013-04 |
EGFR variant III act as the major determinant factors in the EGFR/PI3K/AKT pathway for the survival outcome of oral cancer patients
|
Chang, KY;Tsai, SY;Chen, SH;Tsou, HH;Yen, CJ;Tang, CK;Yen, CY;Chang, JY |
| 國家衛生研究院 |
2013-02 |
OPRM1 genetic polymorphisms are associated with the plasma nicotine metabolite cotinine concentration in methadone maintenance patients: A cross sectional study
|
Chen, YT;Tsou, HH;Kuo, HW;Fang, CP;Wang, SC;Ho, IK;Chang, YS;Chen, CH;Hsiao, CF;Wu, HY;Lin, KM;Chen, ACH;Tsai-Wu, JJ;Liu, YL |
| 臺北醫學大學 |
2013 |
Dissecting the EGFR-P13K-AKT pathway in oral cancer highlights the roles of the EGFR variant III and its clinical relevance
|
Chang, KY;Tsia, SY;Chen, SH;Tsou, HH;Yen, CJ;Liu, KJ;Fang, HL;Wu, HC;Chuang, BF;Chou, SW;Tang, CK;Liu, SY;Lu, PJ;Yen, CY;chang, JY |
顯示項目 71-80 / 116 (共12頁)
<< < 3 4 5 6 7 8 9 10 11 12 > >>
每頁顯示[10|25|50]項目
|
